Plus Therapeutics Inc. (PSTV)
0.66
-0.06 (-8.97%)
At close: Mar 03, 2025, 3:59 PM
0.66
-0.23%
After-hours: Mar 03, 2025, 05:18 PM EST
Plus Therapeutics Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 |
| Revenue | 4.91M | 224K | n/a | 303K | 7M | 2.98M | 6.41M | 11.38M | 11.66M | 7.6M | 12.2M | 14.5M | 10M | 10.63M | 8.89M | 4.53M | 6.05M | 7.93M | 5.63M | 6.82M | 14.09M | 9.17M | 5.65M | 6.25M | 1.51M | n/a |
| Cost of Revenue | 9.69M | 712K | 66K | 2.7M | 5.37M | 1.15M | 1.32M | 2.71M | 3.19M | 2.94M | 3.42M | 4M | 3.84M | 3.91M | 3.39M | 1.85M | 422K | 1.63M | 3.15M | 3.38M | 4.24M | 3.17M | 4.15M | 2.39M | 486K | n/a |
| Gross Profit | -4.78M | -488K | -66K | -2.4M | 1.63M | 1.83M | 5.09M | 8.66M | 8.47M | 4.66M | 8.78M | 10.5M | 6.16M | 6.72M | 5.5M | 2.67M | 5.63M | 6.29M | 2.48M | 3.43M | 9.84M | 6M | 1.5M | 3.86M | 1.03M | n/a |
| Operating Income | -13.32M | -19.71M | -12.49M | -9.58M | -3.66M | -8.76M | -20.68M | -19.71M | -15.29M | -32.44M | -30.68M | -28.42M | -29.41M | -25.32M | -21.55M | -29.76M | -31.35M | -25.86M | -28M | -16.06M | -9.66M | -11.5M | -13.18M | -9.61M | -4.47M | -2.06M |
| Interest Income | 400K | 147K | 19K | 50K | 55K | 43K | 33K | 19K | 9K | 6K | 4K | 4K | 9K | 9K | 20K | 230K | 1.03M | 708K | 299K | 252K | 417K | 1.04M | 2.25M | 1.31M | n/a | 10K |
| Pretax Income | -13.32M | -20.27M | -13.4M | -8.24M | -3.28M | -8.88M | -22.69M | -22.05M | -18.74M | -37.37M | -26.18M | -32.28M | -32.45B | -27.49B | -23.22B | -30.04B | -28.67B | -25.45B | -26.54B | -2.09B | -9.28B | -13B | -11.21B | n/a | n/a | n/a |
| Net Income | -13.32M | -20.84M | -14.33M | -9.35M | -12.74M | -12.63M | -22.69M | -22.05M | -18.74M | -37.37M | -26.18M | -32.28M | -32.45M | -27.49M | -23.22M | -30.04M | -28.67M | -25.45M | -26.54M | -2.09M | -9.28M | -13M | -11.21M | -8.64M | -4.57M | -2.09M |
| Selling & General & Admin | 8.54M | 10.24M | 6.85M | 6.41M | 5.29M | 6.22M | 11.19M | 12.17M | 12.43M | 22.36M | 25.06M | 25.16M | 28.29M | 23.61M | 17M | 16.33M | 16.86M | 14.6M | 15.58M | 8.34M | 9M | 7.94M | 8.07M | 5.18M | 3.67M | 806K |
| Research & Development | 9.69M | 9.7M | 5.57M | 3.48M | 5.37M | 5.52M | 13.36M | 16.2M | 19M | 15.11M | 17.07M | 13.63M | 10.9M | 9.69M | 12.23M | 15.05M | 20.02M | 21.98M | 15.64M | 11.01M | 9.07M | 7.9M | 5.49M | 2.58M | 1.17M | 1.18M |
| Other Expenses | -9.69M | 1K | 6K | 781K | -1.23M | -470K | 13K | 233K | 169K | -608K | -438K | -314K | -1.27M | -1.25M | 3.65M | 1.06M | -5.16M | -10.91M | -742K | 42K | 985K | 1.66M | 1.12M | 5.7M | 661K | 76K |
| Operating Expenses | 8.54M | 19.94M | 12.43M | 9.89M | 10.65M | 11.74M | 25.78M | 28.37M | 31.43M | 37.46M | 42.12M | 38.79M | 39.19M | 32.04M | 33.8M | 32.44M | 31.72M | 25.67M | 30.48M | 19.39M | 19.05M | 17.5M | 14.68M | 13.47M | 5.5M | 2.06M |
| Interest Expense | 395K | 711K | 932K | 1.11M | 1.85M | 1.92M | 2.05M | 2.59M | 3.38M | 4.37M | 3.4M | 3.39M | 2.78M | 2.05M | 1.43M | 420K | 155K | 199K | 137K | 177K | n/a | 263K | 168K | 351K | n/a | 43K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 468K | 643K | 3.59M | 3.61M | 2.66M | 6.41M | 9.03M | 9.49M | 13.56M | 11.04M | 6.58M | 4.6B | 2.67B | 2.06B | 1.43B | 2.39B | 4.42M | 3.99M | 4.49M | 2.63M | 2.36M | 202K |
| Cost & Expenses | 18.23M | 19.94M | 12.43M | 9.89M | 10.65M | 11.74M | 27.09M | 31.09M | 34.61M | 40.4M | 45.54M | 42.79M | 43.03M | 35.95M | 37.2M | 34.29M | 32.14M | 27.31M | 33.63M | 22.77M | 23.3M | 20.67M | 18.83M | 15.86M | 5.99M | 2.06M |
| Income Tax | n/a | 563K | 932K | 1.11M | 9.46M | 1.99M | 2.06M | 2.83M | 3.55M | 3.76M | 7.8M | 2.91M | -790K | 2.02M | -5.13M | 230K | 2.57M | 5.99M | -5.63M | -13.87M | 73K | 1.5M | -1.98M | -964K | 4.57M | 2.09M |
| Shares Outstanding (Basic) | 3.14M | 1.75M | 805.95K | 295.19K | 92.27K | 11.59K | 4.32K | 2.31K | 1.25K | 927.00 | 665.00 | 615.00 | 528.00 | 485.00 | 373.00 | 273.00 | 224.00 | 174.00 | 143.00 | 130.00 | 130.00 | 135.00 | 141.00 | 1.15K | 140.00 | 140.00 |
| Shares Outstanding (Diluted) | 3.14M | 1.75M | 805.95K | 295.19K | 92.27K | 11.59K | 4.32K | 2.31K | 1.25K | 927.00 | 665.00 | 615.00 | 528.00 | 485.00 | 373.00 | 273.00 | 224.00 | 174.00 | 143.00 | 130.00 | 130.00 | 135.00 | 141.00 | 1.15K | 140.00 | 140.00 |
| EPS (Basic) | -4.24 | -11.91 | -17.78 | -31.67 | -138.1 | -1.09K | -5.25K | -9.56K | -14.98K | -40.31K | -39.36K | -52.49K | -61.46K | -56.69K | -62.24K | -110.02K | -128K | -146.25K | -185.58K | -16.08K | -71.41K | -96.32K | -79.48K | -7.53K | -32.65K | -14.93K |
| EPS (Diluted) | -4.24 | -11.91 | -17.78 | -31.67 | -138.1 | -1.09K | -5.25K | -9.56K | -14.98K | -40.31K | -39.36K | -52.49K | -61.46K | -56.69K | -62.24K | -110.02K | -128K | -146.25K | -185.58K | -16.08K | -71.41K | -96.32K | -79.48K | -7.53K | -32.65K | -14.93K |
| EBITDA | -12.69M | -18.85M | -12.49M | -6.76M | -987K | -6.58M | -18.49M | -18.27M | -14.27M | -32.22M | -20.55M | -27.96M | -28.81M | -24.51M | -20.11M | -28.08M | -26.9M | -23.13M | -24.68M | -161K | -7.55M | -10.03M | -10.25M | -9.17M | -4.47M | -2.06M |
| Depreciation & Amortization | 628K | 712K | 419K | 369K | 441K | 379K | 2.15M | 1.18M | 1.09M | 779K | 1.63M | 933K | 855K | 931K | 1.68M | 1.71M | 1.62M | 2.12M | 1.72M | 824K | 1.66M | 1.47M | 1.18M | 441K | n/a | n/a |